RESEARCH OVERVIEW:

  • Report Details: In a low growth environment of increasing regulation, supply chain matters now more than ever. Inventory is (still) at historic highs. While the medical device supply chain will never have single digit inventory levels like high-tech, we see little improvement since 2000 for the peer group. 
  • Objective: Increasing complexity is likely to slow rising revenue per employee metrics.
  • Hypothesis: The chemical industry encounters many of the same problems and offers lessons for medical device companies in a similar upstream placement.


RESEARCH RESULTS:

Full Report

View more documents from Lora Cecere, Abby Mayer and Supply Chain Insights